GHK-Cu: reported timelines in the literature

GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-lysine, also written as glycyl-L-histidyl-L-lysine copper(II) or Gly-His-Lys-Cu²⁺ [2][12]. It is a low-molecular-weight copper-binding peptide; the published literature describes it as a naturally occurring tripeptide present in human plasma and urine, and as a hydrophilic compound with limited permeation through the lipophilic stratum corneum [7][11]. The identifiers given in the evidence are the sequence (glycine-histidine-lysine) and the copper(II) coordination; no molecular weight or CAS number is supplied in the evidence block, so none is stated here.

The work reviewed below centres on copper-dependent redox and catalytic chemistry, on inflammatory signalling through the SIRT1/STAT3 axis, and on stress-response transcription factors of the DAF-16/SKN-1 family [4][6][11].

Research Studies

GHK-Cu and circulating GHK levels in healthy adults

A two-part clinical trial has been registered to measure GHK and GHK-Cu blood levels before and after intervention in healthy adults, and to compare an X39 patch against a placebo patch [1]. The stated primary questions are the change in GHK and GHK-Cu levels from baseline to Day 8, and the difference in that change between the X39 patch and placebo [1]. Participants complete a questionnaire and use the patch [1]. The evidence block gives the design and the Day 8 endpoint; it does not report results, effect sizes or completion status, so no timeline outcome can be quoted from it.

GHK-Cu and topical wound healing in healthy adults

A separate registered study evaluates whether a topical gel containing GHK-Cu can safely speed healing of small, standardized skin wounds in healthy adults compared with a matching vehicle gel [5]. Each participant receives two small punch-biopsy wounds on the upper arm, and each wound is randomly assigned to GHK-Cu gel or vehicle gel under identical dressings [5]. Wounds are photographed and assessed over 3 weeks, with a follow-up visit to evaluate scar quality [5]. The 3-week assessment window is the only timeline the evidence provides for this model; no healing-rate data are reported.

GHK-Cu and Th2 cytokines in an atopic dermatitis model

A complex of Torilis japonica extract and GHK-Cu was formulated and examined for anti-atopic and skin-regenerative properties using a TNF-α/interferon-γ-stimulated model [2]. The paper frames atopic dermatitis as a chronic disorder driven by Th2 immune dysregulation, persistent inflammation and epidermal barrier defects, with oxidative stress acting upstream to amplify inflammatory signals [2]. The reported findings concern attenuation of Th2 cytokines and promotion of keratinocyte recovery [2]. The evidence block does not state the exposure duration or the timepoints at which cytokine or recovery measurements were taken.

GHK-Cu and colitis in a murine DSS model

In BALB/c mice, ulcerative colitis was induced with dextran sulfate sodium, and GHK-Cu was evaluated with emphasis on its regulatory effects on the NAD-dependent deacetylase sirtuin-1 (SIRT1)/signal transducer and activator of transcription 3 (STAT3) signalling pathway [6]. The stated rationale is that GHK-Cu has known anti-inflammatory properties but that its mechanisms in ulcerative colitis remain undefined [6]. This is an animal model; the evidence block does not give the treatment schedule or the day of endpoint assessment.

GHK-Cu and behavioural rescue in middle-aged mice

Middle-aged mice treated with GHK-Cu administered intraperitoneally or intranasally showed behavioural rescue, but the two routes produced divergent hippocampal aging programs [3]. This is an animal study, and the divergence between routes is the reported finding. The evidence block does not supply the dosing interval, the treatment duration, or the behavioural test schedule.

GHK-Cu and skin permeation from liposomal encapsulation

A review addresses whether skin permeation of GHK-Cu can be measured adequately when the tripeptide is encapsulated in liposomes [7]. The stated problem is that cosmetically active compounds of both lipophilic and hydrophilic origin have difficulty reaching deeper skin layers, and that GHK-Cu, being fairly hydrophilic, shows limited permeation through the lipophilic stratum corneum; liposomes capable of encapsulating GHK-Cu may improve that permeation potential [7]. This is a review of measurement and formulation issues rather than a timed exposure study, and no permeation timeline is reported in the evidence block.

GHK-Cu and laccase-like catalytic activity

GHK-Cu has been reported to possess laccase-like properties [4]. In enzymatic reaction kinetics, GHK-Cu showed a Vmax of 1.735 × 10^-4 mM·s^-1 and a Km of 0.061 mM, indicating substrate affinity and catalytic efficiency [4]. A colorimetric method was then developed for rapid detection of epinephrine and 2-aminophenol, with a linear response range of 20–240 μM and a limit of detection of 9.5 μM for epinephrine, and linear response ranges of 14–100 μM for 2-aminophenol [4]. These are in vitro kinetic and analytical figures, not biological timelines.

GHK-Cu and peptide therapeutics in gerontology

A narrative review of therapeutic peptides in gerontology covers mechanisms, clinical applications, evidence base and safety profiles for peptides with demonstrated or potential applications in healthy aging and age-related conditions, targeting hallmarks that include metabolic dysfunction, telomere attrition, tissue repair impairment and hormonal decline [8]. The review is a synthesis; the evidence block does not attribute a specific timeline to GHK-Cu within it.

Comparison of reported model types and stated endpoints

Two further lines of work are noted in the evidence without providing timelines. A review of the regenerative potential of GHK-Cu in aesthetic medicine reports that the peptide has demonstrated regenerative, anti-inflammatory and antioxidant properties in preclinical models, against a background of age-related decline in tissue regenerative capacity [9]. A study of a mixed-culture ferment extract from Thermus thermophilus and Bacillus subtilis combined with GHK-Cu addresses skin aging as a process driven by chronic inflammation and UV exposure, and examines the practice of targeting several pathways simultaneously with a pool of active ingredients [10]. A study in Caenorhabditis elegans reports that GHK-Cu delays aging via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways, with oxidative stress identified as a key contributing factor [11]. A zebrafish larvae study reports that GHK-Cu attenuates copper sulfate- or LPS-induced inflammation [12].

Across the evidence, the only explicit timeframes attached to GHK-Cu are the Day 8 blood-level endpoint in the healthy-adult patch trial [1] and the 3-week wound assessment window in the topical gel trial [5]. Both are registered protocols; the evidence block does not report their results. The animal and in vitro work supplies mechanisms and kinetic constants rather than timelines, and the reviews supply synthesis rather than primary timepoints [3][4][7][8][9].

If you are reading this for personal health reasons

This material is sold for laboratory research use only. We do not provide dosing or medical guidance, and nothing here should be read as a recommendation for use in a person. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

• [1] Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults — https://clinicaltrials.gov/study/NCT07706361
• [2] A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery — https://europepmc.org/article/PMC/PMC13405852
• [3] Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs — https://europepmc.org/article/PMC/PMC13232416
• [4] The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds — https://europepmc.org/article/PMC/PMC13115362
• [5] Topical GHK-Cu Gel for Acute Skin Wound Healing — https://clinicaltrials.gov/study/NCT07437586
• [6] Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms — https://europepmc.org/article/PMC/PMC12263609
• [7] Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes? — https://europepmc.org/article/PMC/PMC11721469
• [8] Therapeutic peptides in gerontology: mechanisms and applications for healthy aging — https://europepmc.org/article/PMC/PMC13095733
• [9] The Regenerative Potential of GHK-Cu in Aesthetic Medicine — https://pubmed.ncbi.nlm.nih.gov/42619529/
• [10] Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu — https://europepmc.org/article/PMC/PMC13455814
• [11] The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways — https://pubmed.ncbi.nlm.nih.gov/42084774/
• [12] Glycyl-L-histidyl-L-lysine-Cu²⁺ (GHK-Cu) Attenuates CuSO4 or LPS induced-inflammation in Zebrafish larvae model — https://pubmed.ncbi.nlm.nih.gov/41997403/